Medicines in Australia are classified into different Schedules as per the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP). The SUSMP is essentially a list of decisions around things like chemical composition, that allow for a Schedule 1 through to Schedule 10 assignment to be made.
The main determiner for schedule listing of medical cannabis products in Australia is the cannabinoid referred to as Tetrahydrocannabinol (THC). Products that contain THC are more controlled and therefore assigned a higher Schedule 8 (S8) rating. Products that do not contain THC, and consist of the cannabinoid known as Cannabidiol (CBD) are less controlled and assigned a lower Schedule 4 (S4 rating).
Approval forms can be downloaded from the TGA or the CannabisAccess medical cannabis portal may be used for online submissions.
Update: As of April 13 2018 state approval is no longer reuqired for medicinal cannabis products. Please see this article for an overview of federal regulations
|State||Schedule Listing||TGA Approval Process|
|QLD||Schedule 4||SAS B|
|QLD||Schedule 8||SAS B|
|NSW||Schedule 4||SAS B|
|NSW||Schedule 8||SAS B|
|ACT||Schedule 4||SAS B|
|ACT||Schedule 8||SAS B|
|VIC, TAS, NT||Schedule 4||SAS B|
|VIC, TAS, NT||Schedule 8||SAS B|
|SA||Schedule 4||SAS B|
|SA||Schedule 8||SAS B|
|WA||Schedule 4||SAS B|
|WA||Schedule 8||SAS B|